Eevia Health Plc to award Select Ingredients an exclusive sales contract on special grade of new cognitive health product.
Eevia Health Plc’s (”Eevia” or ”The Company”) is awarding an exclusive sales agreement to Select Ingredients for a new special formulation for a Tart Cherry extract which will be marketed under the tradename CherryMax®. The sales agreement has binding volumes and minimum sales volume per year. This cooperation is expected to provide for a sales value of over USD 1 million in 2024 and with growth in the coming years.The CherryMax® is a special variant of the tart cherry product range Eevia manufactures. It has scientifically proved effects on human memory and concentration, as well as sleep